Kabra Drugs informs about standalone financial results

15 Feb 2017

Kabra Drugs has informed about Standalone Financial Results, Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

0.82 0.00 (0.00%) Nov 21, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 450.20
Lupin 772.35
Dr. Reddys Lab 2858.80
Piramal Enterprises 1756.85
Cadila Healthcare 254.50
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463